JP2016513474A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513474A5
JP2016513474A5 JP2016502531A JP2016502531A JP2016513474A5 JP 2016513474 A5 JP2016513474 A5 JP 2016513474A5 JP 2016502531 A JP2016502531 A JP 2016502531A JP 2016502531 A JP2016502531 A JP 2016502531A JP 2016513474 A5 JP2016513474 A5 JP 2016513474A5
Authority
JP
Japan
Prior art keywords
mmol
beverage
citrate
citric acid
pyridoxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513474A (ja
JP6581564B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027736 external-priority patent/WO2014152789A1/en
Publication of JP2016513474A publication Critical patent/JP2016513474A/ja
Publication of JP2016513474A5 publication Critical patent/JP2016513474A5/ja
Application granted granted Critical
Publication of JP6581564B2 publication Critical patent/JP6581564B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502531A 2013-03-15 2014-03-14 クエン酸塩を含有した飲料 Active JP6581564B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361793442P 2013-03-15 2013-03-15
US61/793,442 2013-03-15
PCT/US2014/027736 WO2014152789A1 (en) 2013-03-15 2014-03-14 Citrate containing beverage

Publications (3)

Publication Number Publication Date
JP2016513474A JP2016513474A (ja) 2016-05-16
JP2016513474A5 true JP2016513474A5 (enExample) 2017-04-13
JP6581564B2 JP6581564B2 (ja) 2019-09-25

Family

ID=51528113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502531A Active JP6581564B2 (ja) 2013-03-15 2014-03-14 クエン酸塩を含有した飲料

Country Status (11)

Country Link
US (4) US9278112B2 (enExample)
EP (1) EP2983783B1 (enExample)
JP (1) JP6581564B2 (enExample)
CN (1) CN105209120A (enExample)
AU (1) AU2014236553B2 (enExample)
BR (1) BR112015023495A8 (enExample)
CA (1) CA2906907C (enExample)
HK (1) HK1219070A1 (enExample)
MX (1) MX352660B (enExample)
PH (1) PH12015502150A1 (enExample)
WO (1) WO2014152789A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage
US11273140B2 (en) * 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
WO2016159897A1 (en) * 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
US20170035800A1 (en) * 2015-08-06 2017-02-09 Kenneth Davin Fine Reduction of Oxalate Absorption in Individuals
JP6714984B2 (ja) * 2015-08-31 2020-07-01 キリンビバレッジ株式会社 クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料
WO2018080986A1 (en) 2016-10-27 2018-05-03 Seixas Mikelus Stefanie A Juice beverage for prevention and treatment of renal stones
CN108125232A (zh) * 2017-03-07 2018-06-08 浙江欣诺医药有限公司 预防与治疗泌尿系结石的补充剂及其制备方法和应用
US10986857B2 (en) 2017-08-22 2021-04-27 LithoLyte Corporation Dietary supplementation with mixed alkali salts
US11259553B2 (en) 2017-08-22 2022-03-01 Litholyte Corporation, Llc Dietary supplementation with mixed alkali salts
CN108887682A (zh) * 2018-06-09 2018-11-27 夏志君 柠檬酸钠制成柠檬酸钠养生粉及其应用
KR20230005819A (ko) * 2020-04-14 2023-01-10 닛뽕 케미파 가부시키가이샤 수면의 질의 개선제

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165181B (enExample) * 1971-11-08 1974-07-27
US4966776A (en) 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
CN1033349A (zh) * 1987-11-28 1989-06-14 王龙祥 可乐系列饮料的制法
US4985593A (en) 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
CN1438892A (zh) 2000-06-02 2003-08-27 宝洁公司 低碳水化合物组合物、其套盒及其使用方法
CN1284303A (zh) * 2000-09-08 2001-02-21 徐华春 治疗结石的饮料
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
US7323201B2 (en) 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US7897192B2 (en) 2004-10-07 2011-03-01 Next Proteins, Inc. High energy carbonated protein drink and method of making
US7205018B2 (en) 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
US20070077314A1 (en) 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
JP5349744B2 (ja) * 2005-12-19 2013-11-20 松谷化学工業株式会社 ミネラル吸収促進剤、食品及び飼料
MY150223A (en) * 2007-05-18 2013-12-31 Mjn Us Holdings Llc Acidified liquid human milk supplement
GB201012539D0 (en) * 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
WO2012068431A1 (en) 2010-11-18 2012-05-24 The Coca-Cola Company Performance enhancing sports beverage and methods of use
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage

Similar Documents

Publication Publication Date Title
JP2016513474A5 (enExample)
IL283152B2 (en) Preparations containing a high dose of a tetracyclic compound, methods for their preparation and their uses
AR087796A1 (es) Suplemento de micronutrientes
CA2903816C (en) Fertilizer composition and method for preparing the same
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
MX338382B (es) Composicion de gel.
JP2016506747A5 (enExample)
JO3406B1 (ar) عملية لتصنيع منتج صيدلاني يشتمل على حمض الستريك ،أكسيد ماغنسيوم، بيكربونات بوتاسيوم وبيكو كبريتات صوديوم، تركيبة صيدلانية تشتمل على حبيبات متحصل عليها بواسطة هذه العملية ومنتجات وسيطة منها
CL2007002145A1 (es) Precursor de bebida que comprende material de te y aditivo grado alimenticio, metodo para elaborar una bebida ;uso del precursor de bebida;y proceso para elaborar un precursor de bebida.
JP2016513474A (ja) クエン酸塩を含有した飲料
IN2012DN02246A (enExample)
RU2012110758A (ru) Способ получения сахарсодержащего продукта
CL2015001544A1 (es) Método para fabricar sal mineral y producto de sal mineral
MX2017012551A (es) Sal comestible novedosa y util y metodo de uso y produccion de la misma.
MX2022013541A (es) Composiciones de acido gamma-poliglutamico y zinc.
JP2009526748A5 (enExample)
GR20070100787A (el) Υγρο μαγειρικο αλατι.
CN104187098A (zh) 一种添加浒苔粉制作梭子蟹幼蟹饵料的配方
CN102415486A (zh) 观赏鱼饲料
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
WO2010036005A3 (ko) 리세드론산 또는 그의 염 및 비타민 d를 포함하는 약학 조성물
CN102415498A (zh) 优质钓饵
GR20140100338A (el) Οινοπνευματωδες ποτο με βαση το ρουμι με μοσχολεμονο, γλυκαντικες ουσιες, σοδα και φυστικι
CN102415482A (zh) 热带鱼复合饲料
RU2011116842A (ru) Способ приготовления корма для телят 1-6-месячного возраста, предусматривающий введение в рацион опытного минерального премикса (омп-2)